213 related articles for article (PubMed ID: 29278419)
1. Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.
Dripps IJ; Boyer BT; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Br J Pharmacol; 2018 Mar; 175(6):891-901. PubMed ID: 29278419
[TBL] [Abstract][Full Text] [Related]
2. The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.
Dripps IJ; Wang Q; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Psychopharmacology (Berl); 2017 Jan; 234(1):29-39. PubMed ID: 27624599
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Properties of
Dripps IJ; Chen R; Shafer AM; Livingston KE; Disney A; Husbands SM; Traynor JR; Rice KC; Jutkiewicz EM
J Pharmacol Exp Ther; 2020 Aug; 374(2):319-330. PubMed ID: 32467352
[TBL] [Abstract][Full Text] [Related]
4. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.
Nozaki C; Nagase H; Nemoto T; Matifas A; Kieffer BL; Gaveriaux-Ruff C
Br J Pharmacol; 2014 Dec; 171(23):5376-86. PubMed ID: 25048778
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.
Vicente-Sanchez A; Dripps IJ; Tipton AF; Akbari H; Akbari A; Jutkiewicz EM; Pradhan AA
Br J Pharmacol; 2018 Jul; 175(14):3050-3059. PubMed ID: 29722902
[TBL] [Abstract][Full Text] [Related]
6. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
[TBL] [Abstract][Full Text] [Related]
7. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
[TBL] [Abstract][Full Text] [Related]
8. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
Jutkiewicz EM; Rice KC; Traynor JR; Woods JH
Psychopharmacology (Berl); 2005 Nov; 182(4):588-96. PubMed ID: 16163520
[TBL] [Abstract][Full Text] [Related]
9. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents.
Saitoh A; Kimura Y; Suzuki T; Kawai K; Nagase H; Kamei J
J Pharmacol Sci; 2004 Jul; 95(3):374-80. PubMed ID: 15272214
[TBL] [Abstract][Full Text] [Related]
10. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
Psychopharmacology (Berl); 2002 Oct; 164(1):42-8. PubMed ID: 12373418
[TBL] [Abstract][Full Text] [Related]
11. A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice.
Sakamoto K; Yamada D; Yamanaka N; Nishida M; Iio K; Nagase H; Saitoh A
Brain Res; 2021 Apr; 1757():147297. PubMed ID: 33516811
[TBL] [Abstract][Full Text] [Related]
12. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.
Metcalf MD; Yekkirala AS; Powers MD; Kitto KF; Fairbanks CA; Wilcox GL; Portoghese PS
ACS Chem Neurosci; 2012 Jul; 3(7):505-9. PubMed ID: 22860219
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antidepressant-like effects of a delta opioid receptor agonist, SNC80, in rats under inflammatory pain.
Chen CM; Ding H; Mabry KM; Ko MC
Pharmacol Biochem Behav; 2022 Mar; 214():173341. PubMed ID: 35104493
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
15. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
Dripps IJ; Bertels Z; Moye LS; Tipton AF; Siegersma K; Baca SM; Kieffer BL; Pradhan AA
Sci Rep; 2020 Oct; 10(1):17629. PubMed ID: 33077757
[TBL] [Abstract][Full Text] [Related]
16. Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor Function.
Pradhan AA; Perroy J; Walwyn WM; Smith ML; Vicente-Sanchez A; Segura L; Bana A; Kieffer BL; Evans CJ
J Neurosci; 2016 Mar; 36(12):3541-51. PubMed ID: 27013682
[TBL] [Abstract][Full Text] [Related]
17. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.
Pradhan AA; Smith ML; Zyuzin J; Charles A
Br J Pharmacol; 2014 May; 171(9):2375-84. PubMed ID: 24467301
[TBL] [Abstract][Full Text] [Related]
18. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2006 Jun; 317(3):1337-48. PubMed ID: 16537798
[TBL] [Abstract][Full Text] [Related]
19. Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
Negus SS; Rosenberg MB; Altarifi AA; O'Connell RH; Folk JE; Rice KC
J Pain; 2012 Apr; 13(4):317-27. PubMed ID: 22424913
[TBL] [Abstract][Full Text] [Related]
20. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats.
Jutkiewicz EM; Rice KC; Woods JH; Winsauer PJ
Behav Pharmacol; 2003 Nov; 14(7):509-16. PubMed ID: 14557718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
